Dr. David S. Garson, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 42
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 248
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
NY license 166788
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaleida Health Buffalo, NY
- Sisters of Charity Hospital Buffalo, NY
- Mount St. Mary's Hospital & Health Center Lewiston, NY
- Niagara Falls Memorial Medical Center Niagara Falls, NY
Medical groups
- Gastroenterology Associates LLP (30 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 248
- Services billed
- 499
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | 72 |
| Established patient office or other outpatient visit, 30-39 minutes | 59 | 48 |
| Biopsy of large bowel using a flexible endoscope | 49 | 49 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 47 | 47 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | 38 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 31 | 31 |
| Dilation of esophagus | 27 | 26 |
| Established patient office or other outpatient visit, 20-29 minutes | 24 | 24 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Williamsville, NY | 764 |
| Pantoprazole Sodium Other prescribers in Williamsville, NY | 644 |
| Famotidine Other prescribers in Williamsville, NY | 468 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Williamsville, NY | 272 |
| Ondansetron Hcl Other prescribers in Williamsville, NY | 247 |
| Dicyclomine Hcl Other prescribers in Williamsville, NY | 186 |
| Lansoprazole Other prescribers in Williamsville, NY | 89 |
| Diphenoxylate-Atropine (diphenoxylate hcl/atropine) Other prescribers in Williamsville, NY | 79 |
| Prochlorperazine Maleate Other prescribers in Williamsville, NY | 78 |
| Esomeprazole Magnesium Other prescribers in Williamsville, NY | 75 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 71 payments worth $1,370 in total to this clinician.
| AbbVie Inc. | $491 |
|---|---|
| Janssen Biotech, Inc. | $265 |
| Madrigal Pharmaceuticals | $150 |
| Pfizer Inc. | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | $65.31 |
| Ardelyx, Inc. | $53.91 |
| Phathom Pharmaceuticals, Inc. | $50.79 |
| Gilead Sciences, Inc. | $42.49 |
| Food and Beverage | $1,360 |
|---|---|
| Education | $10.48 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc Mar 31, 2025 | Education in-kind | $10.48 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.